The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors. (Q38096241)
Jump to navigation
Jump to search
scientific article published on 05 April 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors. |
scientific article published on 05 April 2013 |
Statements
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors (English)
Prafull Ghatage
John B McIntyre
Pamela Chu
Jill G Nation
Anthony N Karnezis
Guangming Han
Steve E Kalloger
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference